April 2008, Vol. 23 No. 4

Antigenics' Oncophage Registered In Russia For Kidney Cancer Treatment. EU Market Approval For Cephalon's Effentora For Breakthrough Pain. Roche To Buy Piramed For P13-K Inhibitors In Oncology, Other Diseases.

March 2008 Vol. 23 No. 3

Drug Companies Agree To Pay $125 Million To Settle Litigation Over Drug Pricing. Phase III Trial Stopped After Novartis Drug Provides Better PFS In Kidney Cancer. FDA Grants Orphan Status To ActivBiotics Small Molecule.

February 2008, Vol. 23 No. 2

Sanofi-aventis Seeks sNDA For Eloxatin To Include Survival and DFS Data. EMA Issues Positive Opinion On Pharmion's Thalidomide. Mass. General Developing 3D Imaging Technology With Help From NUCAR, NSF. ACORN Beings Phase IIb Trial Of Nexavar In Breast Cancer. Broussard Named President, CEO Of US Oncology.

January 2008, Vol. 23 No. 1

UnitedHealthcare To Base Coverage Of Outpatient Chemo On NCCN Compendium. Semafore, Multiple Myeloma Research Consortium, Begin Phase I Study Of Small Molecule Targeting PI3 Kinase. Cell Therapeutics Buys Zevalin From Biogen Idec. Cephalon Submits NDA For Treanda As Therapy For B-Cell NHL.

December 2007, Vol. 22 No. 11

November 2007, Vol. 22 No. 10

October 2007, Vol. 22 No. 9

September 2007, Vol. 22 No. 8

July 2007, Vol. 22 No. 7

June 2007, Vol. 22 No. 6

May 2007, Vol. 22 No. 5

April 2007, Vol. 22 No. 4